We recently sold the last of our remaining Becton Dickinson portfolio position. Becton remains an extremely well-managed company and finished their fiscal 2017 year (09/30) with strong results. In fact, the company’s top-line of $3.17 billion surpassed expectations by nearly $100 million. In terms of operating segments, BD Medical generated mid-single digit growth, thanks to … Read more
Becton Dickinson is a leader in disposable medical supplies. The company’s stock has dropped 12.5% since hitting $80 in March; however, the company’s fundamentals remain firmly intact and we believe the stock at current levels offers a comfortable margin of safety to our estimate of fair value. Becton Dickinson was formed in 1897 by two … Read more
Becton, Dickinson is the world’s largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell imaging systems. The company is a natural candidate for a strong dividend yield: Its business is such that it will … Read more